Concurrent PRMT5 and TCL1 expression resulted in a more rapid disease onset with increased lymph node involvement and overt lymphomagenesis that appeared to recapitulate disease behavior seen in human RT, representing a model to mimic large B-cell lymphomas that arise from CLL. The gene discussed is PRMT5; the disease is B-cell chronic lymphocytic leukemia.